Significados de artificial pancreas en inglés

Conclusions: HR-informed closed-loop control can be implemented in a portable artificial pancreas.

This model represents another step toward the development of a bihormonal artificial pancreas.

But several trials and another one just beginning are putting the artificial pancreas within reach.

Larger studies are needed to confirm the safety and effectiveness of the new artificial pancreas app.

In 2015 DreaMed licensed its artificial pancreas technology for integration into insulin pumps made by Medtronic Diabetes.

Their two 12-week studies in adults and children are the longest trials ever of an artificial pancreas.

At Harvard University more than two decades of research aims at automating diabetic care by developing an artificial pancreas.

GV is a primary barrier to this optimization, including to automated technologies such as the " artificial pancreas."

Data from a closed-loop artificial pancreas study using a bihormonal controller on T1DM subjects were employed to identify the composite model.

Background: This study evaluated meal bolus insulin delivery strategies and associated postprandial glucose control while using an artificial pancreas (AP) system.

Background: This article describes two novel and easy approaches for assessing the accuracy of insulin pumps as implemented within the artificial pancreas system.

Many patients like the WeAreNotWaiting movement often struggle to get access to upgraded insulin pumps, like the much-sought-after artificial pancreas system.

The results obtained with an artificial pancreas in 34 diabetics (15 women, 19 men) are reported.

Background: A closed-loop system of insulin delivery (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes.

Objective: To evaluate the feasibility of a wearable artificial pancreas system, the Diabetes Assistant (DiAs), which uses a smart phone as a closed-loop control platform.

Background: The utility of simulation environments in the development of an artificial pancreas for type 1 diabetes mellitus (T1DM) management is well established.